The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2025 | Radhakrishnan Anup | See Remarks | Disposed to issuer(D) | 63K | $4.38 | $278K |
| Aug 19, 2025 | Radhakrishnan Anup | See Remarks | Disposed to issuer(D) | 15K | — | — |
| Aug 19, 2025 | Huber Reid M | Director | Disposed to issuer(D) | 25K | — | — |
| Aug 19, 2025 | Bassan Abraham | Director | Disposed to issuer(D) | 25K | — | — |
| Aug 19, 2025 | Henderson Jane | Director | Disposed to issuer(D) | 25K | — | — |
| Aug 19, 2025 | Orwin John A | Director | Disposed to issuer(D) | 25K | — | — |
| Aug 19, 2025 | Orwin John A | Director | Disposed to issuer(D) | 16K | — | — |
| Aug 19, 2025 | Lubner David Charles | Director | Disposed to issuer(D) | 25K | — | — |
| Aug 19, 2025 | Viswanadhan Krishnan | Director | Disposed to issuer(D) | 25K | — | — |
| Aug 19, 2025 | Viswanadhan Krishnan | Director | Disposed to issuer(D) | 3K | — | — |
| Aug 19, 2025 | Dhingra Kapil | Director | Disposed to issuer(D) | 25K | — | — |
| Aug 18, 2025 | Radhakrishnan Anup | See Remarks | Tender(U) | 57K | $4.38 | $251K |
| Jul 2, 2025 | Radhakrishnan Anup | See Remarks | Sell(S) | 2K | $4.18 | $7K |
| Jun 18, 2025 | Orwin John A | Director | Grant(A) | 25K | — | $0 |
| Jun 18, 2025 | Henderson Jane | Director | Grant(A) | 25K | — | $0 |
| Jun 18, 2025 | Lubner David Charles | Director | Grant(A) | 25K | — | $0 |
| Jun 18, 2025 | Dhingra Kapil | Director | Grant(A) | 25K | — | $0 |
| Jun 18, 2025 | Bassan Abraham | Director | Grant(A) | 25K | — | $0 |
| Jun 18, 2025 | Huber Reid M | Director | Grant(A) | 25K | — | $0 |
| Jun 18, 2025 | Viswanadhan Krishnan | Director | Grant(A) | 25K | — | $0 |
| May 14, 2025 | Radhakrishnan Anup | See Remarks | Sell(S) | 27K | $3.84 | $105K |
| May 12, 2025 | Radhakrishnan Anup | See Remarks | Grant(A) | 73K | — | $0 |
| Apr 3, 2025 | Radhakrishnan Anup | See Remarks | Sell(S) | 2K | $4.00 | $7K |
| Mar 14, 2025 | Gadam Shishir | Chief Technical Officer | Grant(A) | 60K | — | $0 |
| Mar 14, 2025 | Chapman Gina | President & CEO, Director | Grant(A) | 200K | — | $0 |
| Mar 14, 2025 | Laport Ginna | Chief Medical Officer | Grant(A) | 50K | — | $0 |
| Mar 14, 2025 | Radhakrishnan Anup | See Remarks | Grant(A) | 73K | — | $0 |
| Nov 15, 2024 | Radhakrishnan Anup | See Remarks | Grant(A) | 40K | — | $0 |
| Sep 19, 2024 | Chapman Gina | President & CEO, Director | Option exercise(M) | 3K | $5.03 | $15K |
| Sep 19, 2024 | Chapman Gina | President & CEO, Director | Sell(S) | 3K | $25.03 | $74K |
| Sep 19, 2024 | Chapman Gina | President & CEO, Director | Option exercise(M) | 3K | — | $0 |
| Sep 18, 2024 | Radhakrishnan Anup | Chief Financial Officer | Option exercise(M) | 2K | $5.03 | $8K |
| Sep 18, 2024 | Radhakrishnan Anup | Chief Financial Officer | Sell(S) | 2K | $25.28 | $40K |
| Sep 18, 2024 | Radhakrishnan Anup | Chief Financial Officer | Option exercise(M) | 2K | — | $0 |
| Sep 18, 2024 | Chapman Gina | President & CEO, Director | Sell(S) | 7K | $25.09 | $180K |
| Sep 18, 2024 | Chapman Gina | President & CEO, Director | Option exercise(M) | 7K | $5.03 | $36K |
| Sep 18, 2024 | Chapman Gina | President & CEO, Director | Option exercise(M) | 7K | — | $0 |
| Jun 4, 2024 | Henderson Jane | Director | Grant(A) | 20K | — | $0 |
| Jun 4, 2024 | Henderson Jane | Director | Grant(A) | 39K | — | $0 |
| Jun 4, 2024 | Orwin John A | Director | Grant(A) | 24K | — | $0 |
| Jun 4, 2024 | Huber Reid M | Director | Grant(A) | 24K | — | $0 |
| Jun 4, 2024 | Lubner David Charles | Director | Grant(A) | 24K | — | $0 |
| Jun 4, 2024 | Viswanadhan Krishnan | Director | Grant(A) | 24K | — | $0 |
| Jun 4, 2024 | Bassan Abraham | Director | Grant(A) | 24K | — | $0 |
| Jun 4, 2024 | Dhingra Kapil | Director | Grant(A) | 12K | — | $0 |
| May 30, 2024 | Samsara BioCapital, L.P. | 10% Owner | Buy(P) | 294K | $17.00 | $5.0M |
| Apr 15, 2024 | Dhingra Kapil | Director | Grant(A) | 49K | — | $0 |
| Mar 1, 2024 | Chapman Gina | President & CEO, Director | Grant(A) | 400K | — | $0 |
| Mar 1, 2024 | Radhakrishnan Anup | Chief Financial Officer | Grant(A) | 130K | — | $0 |
| Mar 1, 2024 | Gadam Shishir | Chief Technical Officer | Grant(A) | 100K | — | $0 |
| Mar 1, 2024 | Laport Ginna | Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Jan 12, 2024 | RTW Investments, LP | 10% Owner | Other(J) | 1.8M | — | — |
| Nov 14, 2023 | TRV GP V, LLC | 10% Owner | Conversion(C) | 474K | — | — |
| Nov 14, 2023 | TRV GP V, LLC | 10% Owner | Buy(P) | 1.3M | $15.00 | $20.0M |
| Nov 14, 2023 | TRV GP V, LLC | 10% Owner | Conversion(C) | 1.7M | — | — |
| Nov 14, 2023 | TRV GP V, LLC | 10% Owner | Conversion(C) | 6.4M | — | $0 |
| Nov 14, 2023 | TRV GP V, LLC | 10% Owner | Conversion(C) | 23.6M | — | $0 |
| Nov 14, 2023 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 737K | — | — |
| Nov 14, 2023 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 10.0M | — | $0 |
| Nov 14, 2023 | Edelman Joseph | Insider | Buy(P) | 333K | $15.00 | $5.0M |
| Nov 14, 2023 | Edelman Joseph | Insider | Buy(P) | 333K | $15.00 | $5.0M |
| Nov 14, 2023 | Edelman Joseph | Insider | Conversion(C) | 2.6M | — | — |
| Nov 14, 2023 | Edelman Joseph | Insider | Conversion(C) | 2.6M | — | — |
| Nov 14, 2023 | Akkaraju Srinivas | 10% Owner | Buy(P) | 667K | $15.00 | $10.0M |
| Nov 14, 2023 | Akkaraju Srinivas | 10% Owner | Conversion(C) | 3.4M | — | — |
| Nov 14, 2023 | Akkaraju Srinivas | 10% Owner | Conversion(C) | 1.8M | — | $0 |
| Nov 14, 2023 | Akkaraju Srinivas | 10% Owner | Conversion(C) | 663K | — | $0 |
| Nov 14, 2023 | Akkaraju Srinivas | 10% Owner | Conversion(C) | 884K | — | $0 |
| Nov 9, 2023 | Bassan Abraham | Director | Grant(A) | 25K | — | $0 |
| Nov 9, 2023 | Huber Reid M | Director | Grant(A) | 25K | — | $0 |
| Nov 9, 2023 | Viswanadhan Krishnan | Director | Grant(A) | 25K | — | $0 |
| Nov 9, 2023 | Orwin John A | Director | Grant(A) | 25K | — | $0 |
| Nov 9, 2023 | Lubner David Charles | Director | Grant(A) | 25K | — | $0 |
| Nov 9, 2023 | Radhakrishnan Anup | Chief Financial Officer | Grant(A) | 100K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).